Hyperglycemia and nutrition support: Theory and practice

Nutrition in Clinical Practice

Volumn 19, Issue 3, 2004, Pages 235-244

  McCowen, Karen C ^a   Bistrian, Bruce R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

DISEASE SEVERITY; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IATROGENIC DISEASE; INSULIN TREATMENT; INTENSIVE CARE; MORTALITY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PROGNOSIS; REVIEW; SURGICAL PATIENT; SURGICAL STRESS;

EID: 2942562033     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426504019003235     Document Type: Review

References (74)

1. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN. 1998;22:77-81.
2. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort ofadults with diabetes. Diabetes Care. 1999;22:1408-1414.
3. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047.
4. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49:531-537.
5. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001;32:2426-2442.
6. Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990;47:1174-1177.
7. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-1478.
8. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet. 2000;355:773-778.
9. Margulies DR, Hiatt JR, Vinson D Jr, Shabot MM. Relationship of hyperglycemia and severity of illness to neurologic outcome in head injury patients. Am Surg. 1994;60:387-390.
10. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med. 2001;345:1359-1367.
11. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107-124.
12. Shamoon H, Hendler R, Sherwin RS. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab. 1981;52:1235-1241.
13. Gelfand RA, Matthews DE, Bier DM, Sherwin RS. Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest. 1984;74:2238-2248.
14. Watters JM, Kirkpatrick SM, Hopbach D, Norris SB. Aging exaggerates the blood glucose response to TPN. Can J Surg. 1996;39:481-485.
15. Heise T, Heinemann L, Starke AA. Simulated postaggression metabolism in healthy subjects: Metabolic changes and insulin resistance. Metabolism. 1998;47:1263-1268.
16. Jeevanandam M, Young DH, Schiller WR. Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma. 1990;30:582-589.
17. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97:2859-2865.
18. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism. 1988;37:802-806.
19. Desai D, March R, Watters JM. Hyperglycemia after trauma increases with age. J Trauma. 1989;29:719-723.
20. Frankenfield D, Cooney RN, Smith JS, Rowe WA. Age-related differences in the metabolic response to injury. J Trauma. 2000;48:49-56.
21. Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associated deterioration in glucose tolerance: Contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003;52:1738-1748.
22. Dahn MS, Jacobs LA, Smith S, et al. The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg. 1985;120:166-172.
23. Werb MR, Zinman B, Teasdale SJ, Goldman BS, Scully HE, Marliss EB. Hormonal and metabolic responses during coronary artery bypass surgery: Role of infused glucose. J Clin Endocrinol Metab. 1989;69:1010-1018.
24. Baum D, Porte D Jr. Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism. 1980;29:1176-1185.
25. Ortiz-Alonso FJ, Herman WH, Zobel DL, Perry TJ, Smith MJ, Halter JB. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM. Diabetes. 1991;40:1194-1202.
26. Fietsam R Jr, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg. 1991;57:551-557.
27. Khaodhiar L, McCowen K, Bistrian B. Perioperative hyperglycemia, infection or risk? Curr Opin Clin Nutr Metab Care. 1999;2:79-82.
28. Kwoun MO, Ling PR, Lydon E, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN. 1997;21:91-95.
29. Saiepour D, Sehlin J, Oldenborg PA. Hyperglycemia-induced protein kinase C activation inhibits phagocytosis of c3b- and immunoglobulin g-opsonized yeast particles in normal human neutrophils. Int J Exp Diabesity Res. 2003;4:125-132.
30. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med. 2003;29:642-645.
31. Rassias AJ, Marrin CA, Arruda J, Whalen PK, Beach M, Yeager MP. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg. 1999;88:1011-1016.
32. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. JPEN. 1991;15:60-64.
33. Ling PR, Mueller C, Smith RJ, Bistrian BR. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism. 2003;52:868-874.
34. Gross ER, LaDisa JF Jr, Weihrauch D, et al. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol. 2003;284:H1552-H1559.
35. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: Role of hyperglycemia and hyperinsulinemia. Circulation. 2000;101:2247-2251.
36. Song EC, Chu K, Jeong SW, et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 2003;34:2215-2220.
37. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002;30:2438-2442.
38. Flakoll PJ, Hill JO, Abumrad NN. Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol. 1993;265:E715-E721.
39. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
40. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-360.
41. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
42. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
43. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-853.
44. Kilo C, Miller JP, Williamson JR. The Achilles heel of the University Group Diabetes Program. JAMA. 1980;243:450-457.
45. Leibowitz G, Cerasi E. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: A mixed blessing? Diabetologia. 1996;39:503-514.
46. van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
47. Ceremuzynski L, Budaj A, Czepiel A, et al. Low-dose glucoseinsulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999;13:191-200.
48. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation. 1998;98:2227-2234.
49. Castro PF, Larrain G, Baeza R, et al. Effects of Glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med. 2003;31:2152-2155.
50. van der Horst IC, Zijlstra F, van't Hof AW, et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: A randomized trial. J Am Coll Cardiol. 2003;42:784-791.
51. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
52. Wong V, Cheung NW, Boyages SC. Glycometabolic status and acute myocardial infarction: Has the time come for glucose-insulin-(potassium) therapy? Intern Med J. 2003;33:443-449.
53. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222:283-297.
54. Pierre EJ, Barrow RE, Hawkins HK, et al. Effects of insulin on wound healing. J Trauma. 1998;44:342-345.
55. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction: DIGAMI Study Group: Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J. 1996;17:1337-1344.
56. Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab. 2001;86:3257-3265.
57. Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: The Paris Prospective Study, ten years later. Horm Metab Res Suppl 1985;15:41-46.
58. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11:151-156.
59. Sheridan RL, Yu YM, Prelack K, Young VR, Burke JF, Tompkins RG. Maximal parenteral glucose oxidation in hypermetabolic young children: A stable isotope study. JPEN. 1998;22:212-216.
60. Kim H, Son E, Kim J, et al. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving TPN. Am J Health Syst Pharm. 2003;60:1760-1766.
61. Chiolero R, Schneiter P, Cayeux C, et al. Metabolic and respiratory effects of sodium lactate during short i.v. nutrition in critically ill patients. JPEN. 1996;20:257-263.
62. McCowen KC, Friel C, Sternberg J, et al. Hypocaloric TPN: Effectiveness in prevention of hyperglycemia and infectious complications: A randomized, clinical trial. Critical Care Med. 2000;28:3606-3611.
63. Frankenfield DC, Smith JS, Cooney RN. Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance. JPEN. 1997;21:324-329.
64. Pomposelli JJ, Bistrian BR. Is TPN immunosuppressive? New Horiz. 1994;2:224-229.
65. McCowen KC, Chan S, Bistrian BR. Total parenteral nutrition. Cur Opin Gastroenterol. 1998;14:157-163.
66. Tappy L, Schwarz JM, Schneiter P, et al. Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients. Crit Care Med. 1998;26:860-867.
67. Muscaritoli M, Conversano L, Torelli GF, et al. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation. 1998;66:610-616.
68. Meguid MM, Akahoshi MP, Jeffers S, Hayashi RJ, Hammond WG. Amelioration of metabolic complications of conventional TPN: A prospective randomized study. Arch Surg. 1984;119:1294-1298.
69. Hart DW, Wolf SE, Zhang XJ, et al. Efficacy of a High-carbohydrate diet in catabolic illness. Crit Care Med. 2001;29:1318-1324.
70. Hunter DC, Jaksic T, Lewis D, Benotti PN, Blackburn GL, Bistrian BR. Resting energy expenditure in the critically ill: Estimations versus measurement. Br J Surg. 1988;75:875-878.
71. Choban PS, Burge JC, Scales D, Flancbaum L. Hypoenergetic nutrition support in hospitalized obese patients: A simplified method for clinical application. Am J Clin Nutr. 1997;66:546-550.
72. Dazzi D, Taddei F, Gavarini A, Uggeri E, Negro R, Pezzarossa A. The control of blood glucose in the critical diabetic patient: A neuro-fuzzy method. J Diabetes Complications. 2001;15:80-87.
73. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
74. Sanderson I, Deitel M. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Ann Surg. 1974;179:387-394.